Hydrocephaly-cerebellar agenesis syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1397OMIM:307010Q04.3
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Hydrocephaly-cerebellar agenesis syndrome is an extremely rare congenital malformation of the central nervous system characterized by the combination of hydrocephalus (abnormal accumulation of cerebrospinal fluid within the brain) and complete or near-complete absence (agenesis) of the cerebellum. The cerebellum is the part of the brain responsible for coordinating movement, balance, and muscle tone. This syndrome primarily affects the central nervous system and manifests at birth or prenatally. Key clinical features include severe hydrocephalus with enlarged head circumference (macrocephaly), absence or severe hypoplasia of the cerebellum, and associated neurological impairments including profound developmental delay, hypotonia (reduced muscle tone), and motor dysfunction. Additional brain malformations may be present in some cases. The condition is typically identified during the neonatal period, often detected prenatally through ultrasound imaging showing ventriculomegaly and absent cerebellar structures. Affected infants generally present with significant neurological compromise. The prognosis is typically very poor, with many cases resulting in early death. Treatment is primarily supportive and symptomatic. Surgical intervention such as ventriculoperitoneal shunting may be performed to manage hydrocephalus and reduce intracranial pressure, but this does not address the underlying cerebellar agenesis. Developmental support, physical therapy, and management of associated complications form the basis of ongoing care. Due to the extreme rarity of this condition, there are no disease-specific therapies, and management is guided by individual clinical presentation.

Clinical phenotype terms— hover any for plain English:

Cerebellar agenesisHP:0012642
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Hydrocephaly-cerebellar agenesis syndrome.

View clinical trials →

No actively recruiting trials found for Hydrocephaly-cerebellar agenesis syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Hydrocephaly-cerebellar agenesis syndrome community →

No specialists are currently listed for Hydrocephaly-cerebellar agenesis syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Hydrocephaly-cerebellar agenesis syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Hydrocephaly-cerebellar agenesis syndromeForum →

No community posts yet. Be the first to share your experience with Hydrocephaly-cerebellar agenesis syndrome.

Start the conversation →

Latest news about Hydrocephaly-cerebellar agenesis syndrome

No recent news articles for Hydrocephaly-cerebellar agenesis syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Hydrocephaly-cerebellar agenesis syndrome

What is Hydrocephaly-cerebellar agenesis syndrome?

Hydrocephaly-cerebellar agenesis syndrome is an extremely rare congenital malformation of the central nervous system characterized by the combination of hydrocephalus (abnormal accumulation of cerebrospinal fluid within the brain) and complete or near-complete absence (agenesis) of the cerebellum. The cerebellum is the part of the brain responsible for coordinating movement, balance, and muscle tone. This syndrome primarily affects the central nervous system and manifests at birth or prenatally. Key clinical features include severe hydrocephalus with enlarged head circumference (macrocephaly),

How is Hydrocephaly-cerebellar agenesis syndrome inherited?

Hydrocephaly-cerebellar agenesis syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Hydrocephaly-cerebellar agenesis syndrome typically begin?

Typical onset of Hydrocephaly-cerebellar agenesis syndrome is neonatal. Age of onset can vary across affected individuals.